Clinical Trial Update: A Local Register Study For Major Depression Of Paroxetine Controlled Release [Phase 3]

View source ↗

Summary

A Phase 3 local register study evaluating paroxetine controlled release for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Paxil CR (paroxetine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major, Major Depressive Disorder (MDD) | Phase 3 | Status: COMPLETED